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AIM: Acinetobacter baumannii is a ubiquitous gram-negative bacterium found on
a variety of surfaces that include skin, hair, and soil. Some gram-negative bacteria like A.
baumannii have the ability to acquire and incorporate fatty acids into their phospholipid
membranes. Known as ‘Iraqibacter,’ A. baumannii has emerged as a significant cause of
nosocomial infections in the United States and abroad. This study was designed to
determine whether structural alterations occur in A. baumannii upon exposure to a wide
range of polyunsaturated fatty acids (PUFAs) as well as the significance of this
phenomenon in terms of survival and resistance to stress.
METHODS: Thin layer chromatography of isolated phospholipids indicated
phospholipid profile variation depending on the exogenous PUFA supplied. To assess the
incorporation of exogenous fatty acids with A. baumannii phospholipids, isolated lipids
were analyzed by ultra-performance liquid chromatography/mass spectrometry
(UPLC/MS). Membrane permeability was assessed with a crystal violet hydrophobic
compound uptake assay. An assay for biofilm formation was performed to indicate the
production of biofilms among bacterial growth in the presence of each fatty acid. To
observe additional phenotypic responses, environmental stresses such as hydrogen
peroxide, antimicrobial peptide, and antibiotic pressures were assayed.
RESULTS & CONCLUSION: The fatty acids affected membrane permeability,
as determined by a hydrophobic compound uptake test. At least a 20% range of uptake
was observed between the PUFAs examined. Bacterial growth in the presence of each
PUFA caused an increase in biofilm production. As expected, numerous unique
phospholipid species were identified and were bioinformatically predicted to contain the
exogenously supplied PUFA as one of their acyl chains. While no differences in
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minimum inhibitory concentrations were observed with peroxide and beta-lactam
antibiotic stresses, sensitivity of A. baumannii to two different antimicrobial peptides,
colistin and polymyxin B, increased following growth in several of the PUFAs, with
arachidonic acid displaying the highest inhibition. Since cationic antimicrobial peptides
are believed to interact with bacterial lipid membranes for eventual pore formation, these
results implicate exogenous fatty acids as modification moieties that may impact
resistance to environmental stresses.

III. INTRODUCTION
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One of the most prevalent challenges in the realm of healthcare has arisen in the
form of multidrug-resistant bacteria. Examples of flourishing bacteria include
Staphylococcus aureus, Pseudomonas aeruginosa, Klebsiella pneumoniae, and
Acinetobacter baumannii. These are four of six ‘ESKAPE bugs’ that were classified by
the Infectious Diseases Society of America in 2008. ESKAPE bugs “are of immediate US
health concern that collectively cause the majority of nosocomial infections and can
escape therapeutic activity of currently available antibiotics.”1 A. baumannii does not
desiccate easily and is notably responsible for a number of hospital-acquired diseases that
affect various systems in the body. These diseases are typically difficult to treat and
mainly affect individuals who are on ventilation or have previous wounds.2,3 It was also
given the nickname “Iraqibacter” after causing a spike in A. baumannii infections on
wounded soldiers during the war in Iraq, which in turn caused a global spread of the bug
as soldiers returned home. One publicized example of this occurred when ABC news
correspondent Bob Woodruff became infected by A. baumannii in Iraqi soil from a
roadside bomb in January of 2006, causing sepsis and pneumonia. He ultimately lived
after losing part of his skull, but this instance is only one of numerous cases of A.
baumannii occurring all over the world.4
A. baumannii is a gram-negative bacterium. Unlike gram-positive bacteria that
have a single cellular membrane, gram-negative bacteria such as A. baumannii are
defined by an inner and outer cell membrane with a periplasmic space and thin
peptidoglycan layer in between. Therefore, import and export transport systems in these
bacteria must exhibit cooperation between inner and outer membranes.5,6 A. baumannii is
regarded as a universal organism and can inhabit a variety of surfaces including human
skin and hair as well as soil, and it is able to persist and survive in numerous types of
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environments.7 Infections of A. baumannii can lead to problems in the lungs, spinal cord,
blood, urinary tract, or skin. While some A. baumannii infections are treatable, many of
them can be fatal, especially if they are not noticed or treated quickly.
Some gram-negative bacteria have evolved pathways to utilize fatty acids as
carbon sources, with their degradation ultimately leading to production of ATP. More
recently, it has been discovered that exogenous fatty acids can be taken up by A.
baumannii and incorporated into their membranes (Giles lab, unpublished data). The
mechanism of the uptake of fatty acids by gram-negative bacteria begins with FadL, a
transporter that resides in the outer membrane of the cell. When FadL binds to and
transfers a fatty acid through the outer membrane of the cell, the fatty acid navigates
through the periplasm and travels to the cytosolic face of the inner membrane, where it is
joined with coenzyme A (CoA) via the enzyme FadD, yielding acyl-CoA. Now joined to
a carrier molecule, acyl-CoA can be used as a carbon energy source in the β -oxidation
pathway or can go back to the membrane; in the membrane, acyltransferases integrate the
new fatty acid into membrane phospholipids.8 Although several bacteria possess
machinery to recycle exogenous fatty acids into their own membrane, there is no data to
show how these scavenged fatty acids benefit the bacteria. The aim of this study is to
explore fatty acid assimilation in A. baumannii and to examine potential survival and
resistive advantages gained by lipid membrane remodeling.
The scale of infections and diseases that A. baumannii has the ability to cause is
extremely vast and broad. The Centers for Disease Control and Prevention estimate that
approximately 80% of all reported infections in healthcare facilities arise from A.
baumannii.9 Healthy people do not have as great a probability of contracting disease from
A. baumannii, as it is typically seen within all types of healthcare settings, but
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specifically in veterans’ hospitals and intensive care units. Those who do contract the
bacteria usually have compromised immune systems, diabetes, lung problems, open
wounds, long hospital stays, or have invasive devices in them such as catheters or
ventilators. A. baumannii can be transmitted either by contact with an infected individual
or a contaminated surface.10 Soldiers infected by “Iraqibacter” in Iraq and Afghanistan
have reported cases of osteomyelitis, bacteremia, and various respiratory and wound
infections. Researchers believe that rather than being infected via the soil or debris
directly, military medical establishments are the source of most A. baumannii infections
among soldiers. It is likely that a few individuals contracted it from soil or debris, which
was then subsequently spread in medical facilities. Mortality rates related to A.
baumannii infections are fairly high, whether their deaths are directly linked to the
bacteria or other underlying problems.2 This is most likely a result of the pre-existing
medical conditions associated with the general population of people affected by A.
baumannii, as mentioned before.
Due to its persistent nature, A. baumannii will always be around as long as there
are vulnerable patients and lack of compliance towards infection control by healthcare
providers.2 While there are several preventative measures that can be taken to avoid
exposure to the bacteria, the most common method of treating it is through antibiotics.
Common treatment agents against A. baumannii include carbapenems, lactamase
inhibitors, tigecycline, aminoglycosides, and polymyxin therapy.2 Most forms of
antibiotics, however, have become an issue as the number of multidrug-resistant strains
of A. baumannii has risen.
To address our hypothesis that exogenous fatty acids can be utilized by A.
baumannii, we first determined how the membrane of A. baumannii is modified
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structurally and how these alterations may benefit the bacteria’s survival and resistance to
stress. We analyzed phospholipid species to see if the bacteria were in fact incorporating
fatty acids in their membranes. Ultra-performance liquid chromatography/mass
spectrometry confirmed that new phospholipid species were produced depending on the
fatty acid supplied. After this confirmation, we tested the effects of exogenous fatty acids
on hydrophobic compound uptake. Finally, the effects of environmental stresses were
investigated through a series of tests and assays that established how various phenotypic
stresses affect A. baumannii based on its ability to uptake exogenous fatty acids.
Understanding the capabilities of A. baumannii is of great importance in
microbiology and public health fields. Studying A. baumannii can also have a potential
effect on the global scale, as “Iraqibacter” is highly multi-drug resistant in nature and has
rapidly spread in a short period of time. Ideally, the tests conducted in this experiment
will help better understand the survival and virulence of A. baumannii so that we may be
better prepared to contend with the bacteria holistically. These studies may also give
insight to methods that may improve treatments of diseases caused by A. baumannii
worldwide in the most effective and efficient manner.

IV. METHODOLOGY
MATERIALS
The following fatty acids were collectively used throughout the entirety of this project:
linoleic acid (18:2), α -linolenic acid (18:3α ), γ -linolenic acid (18:3γ ), dihomo
dihomo-γ -linolenic
acid (20:3), arachidonic acid (20:4), eicosapentaenoic acid (20:5), docosapentaenoic acid
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(22:5), and docosahexaenoic acid (22:6). The strain of Acinetobacter baumannii used was
ATCC 17978. Fatty acids and bacteria were obtained through Cayman Chemical and the
American Type Culture Collection, respectively. Bacteria were grown in either Luria
broth (LB) or G-56 minimal media. G-56 was buffered with Hepes (pH 7.4) and
supplemented with KH2PO4 (0.3 mM), KCl (10 mM), (NH4)2SO4 (10 mM), glucose
(0.2%), FeSO4 (0.03 mM), and thiamine (0.075 mM) as well as additional additives of
CaCl2 (1 mM), MgSO4 (1 mM), and casamino acids (0.4%). G-56 was prepared the same
day it was used after being filter sterilized. Crystal violet (CV) was purchased from
Fisher Scientific, imipenem from LKT Laboratories, Inc., colistin (polymyxin E) from
Adipogen International, and polymyxin B (PMB) from Cayman Chemical.
PREPARATION OF BACTERIAL CULTURES
Bacterial cultures were prepared uniformly each time an assay was performed. To begin,
A. baumannii (ATCC 17978) was streaked onto an LB agar plate and left in the 37°C
incubator overnight. The plate was removed the next day and placed into the refrigerator,
where it remained fresh for at least two weeks. Every two weeks a new plate was
streaked to maintain consistently fresh bacterial colonies. Overnight cultures were set
each evening prior to running an experiment, which were grown in LB broth tubes in a
37°C shaking incubator.
GROWTH CURVE
Overnight cultures were pelleted, washed in G-56 (pH 7.4), and used to inoculate fresh
cultures in G-56 at a starting optical density of 0.05. 300 µM
M of each fatty acid (18:2,
18:3α , 18:3γ , 20:3, 20:4, 22:5, and 22:6) was supplemented to the appropriate cultures.
The prepared bacteria was placed in the 37°C shaking incubator (200 rpm). Optical
densities were read every 30 minutes for a total of eight hours, followed by an additional
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reading five hours later as well as twelve hours after that, yielding a total observation of
twenty five hours of growth.
LIPID EXTRACTION AND THIN LAYER CHROMATOGRAPHY
Bacteria were grown at 37°C. Once reaching an optical density between 0.8 and 1.0,
cultures were pelleted for 10 minutes. The supernatant was poured off, followed by the
washing of the residual pellet in 5mL of phosphate buffered saline (PBS) that was then
centrifuged for an additional 10 minutes. Again, the supernatant was removed, and the
remaining pellet was resuspended in 5 mL of single phase Bligh/Dyer mixture. This
mixture is made up of chloroform/methanol/water in a 1:2:0.8 ratio. Once resuspended,
the culture is vortexed and incubated for a total of 20 minutes at room temperature,
followed by a 10-minute centrifugation. The supernatant was drawn off and put into a
new glass tube while the pellet was disposed of, as it was no longer necessary. In order to
make the single phase Bligh/Dyer mixture into a two-phase mixture, 1.3 mL of
chloroform and 1.3 mL of water were supplemented to the single phase mixture that was
then vortexed and centrifuged for 10 minutes. Centrifugation creates a lower and upper
phase of the mixture; the lower phase was drawn into a fresh glass vial, while 2.6 mL of
chloroform was added to the upper phase. The vortex, centrifugation, and extraction step
was performed once more, and the collective extractions were further washed by adding
5.2 mL of methanol and 4.7 mL of water. The final extraction was collected and dried
down under a stream of nitrogen. The remaining lipids were kept in -20°C until the thin
layer chromatography took place.10, 11
Thin layer chromatography was used to analyze lipids via a solvent made up of
chloroform/methanol/acetic acid in a 65:25:10 ratio.12 The chromatography creates lipid
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profiles that were visualized using a spray of 10% sulfuric acid in 100% ethanol and
heating the plate to 200°C.
ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY & MASS
SPECTROMETRY
Ultra performance liquid chromatography (UPLC) and mass spectrometry were used to
determine the mass to charge ratio of phospholipid species in A. baumannii after they
were grown in the presence and absence of various fatty acids. These are two separate
processes, with UPLC used to separate lipids and mass spectrometry used to detect and
assign specific mass to charge ratios to the species as they are ionized. Structural
assignments were generated using the Lipid Metabolites And Pathways Strategy database
(Lipid MAPS).12 Mobile phase A consisted of 30:70 (25 mM ammonium acetate [pH
6.7]: methanol), and mobile phase B was 100% methanol. Isolated phospholipids were
weighed, and 300 parts per million (ppm) were paired in 1 mL diluent (50:50 mobile
phase A: mobile phase B) prior to injection into a Waters UPLC equipped with a
reversed-phased C8 column. The injection volume was 5 µL,
L, the run time was 15
minutes, and the flow rate was 0.4 µL/minute.
L/minute. The gradient was 50:50 up until the 22
minute mark, where it shifted to 20:80 until the 12-minute mark. Between 12 and 12.2
minutes, the gradient shifted back to 50:50 until the end of the run. Detection was by
quadrupole mass spectrometry using electrospray ionization in the negative mode.
CRYSTAL VIOLET UPTAKE
Overnight cultures of A. baumannii were pelleted, washed, and used to inoculate in G-56
media at a starting optical density of 0.1. These cultures were supplemented with each of
the following fatty acids: 18:2, 18:3α , 18:3γ , 20:3, 20:4, 20:5, 22:5, and 22:6. Once the
cells had grown to an OD600nm of approximately 1.0, they were transferred into sterile
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plastic tubes and centrifuged for 10 minutes at 4000 rpm. Media was removed and the
cells were washed with PBS. Each culture was suspended in 1 mL PBS and the optical
density was determined. Cultures of equal starting OD were prepared in 5 mL of PBS,
and 5 µL
L of 5 mg/mL crystal violet solution was added (final concentration of 5 µg/mL)
g/mL).
The tubes were agitated at room temperature, and the optical density was read every five
minutes for a total of 25 minutes. To read the optical density, 800 µL
L of each culture was
micro-centrifuged for one minute at 1200 g. The supernatant was analyzed
spectrophotometrically for absorbance at OD590nm.
BIOFILM FORMATION
The protocol to test for biofilm formation was borrowed for a method by the O’Toole
assay.13 Overnight cultures were pelleted, washed in PBS, and prepared at an OD of 0.1.
In the appropriate media, 300 µM
M of each fatty acid (18:3γ , 20:3, 20:4, and 22:6) was
added to each culture. Microtiter plates were used for this assay, with each inoculum
placed into its respective wells and grown overnight statically or shaking in the 30°C or
37°C incubator. After 24 hours, the biofilm was to be stained following O’Toole’s
protocol again. Excess cells were first removed by shaking the liquid out of each
microtiter plate. The plate was submerged in a small tub of distilled water and then
shaken to remove additional liquid. This step was repeated two or three times until
planktonic cells were confidently discarded. At this point, 125 µL
L of 0.1% crystal violet
solution was added to each of the wells in the microtiter plate and incubated at room
temperature for 10-15 minutes. The crystal violet was rinsed out of the plate by gently
submerging it in distilled water three to four times followed by vigorous blotting on a
paper towel. Once the crystal violet was rinsed out, the plate was dried upside down
overnight. After 24 hours, 125 µL
L of a prepared solution of 30% acetic acid was added to
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each well in the microtiter plate to solubilize the crystal violet. This incubated at room
temperature for 10-15 minutes as well. 125 µL
L of the solubilized crystal violet was
transferred into a new microtiter dish and read on a Biotek Microplate reader with Gensys
software. The biofilm assay was conducted several times, with manipulating variables
including temperature, pH, and incubation (shaking vs. static). A two-tailed T-test was
done to determine which data points reflect significant differences.
MOTILITY TEST
To begin the setup for the motility test, five plastic tubes were prepared, each with 1 mL
of LB and the appropriate amount of fatty acids required (18:3γ , 20:3, 20:4, and 22:6).
These were grown in a 37°C shaking incubator until they reached an OD of 0.1 and the
calculated amounts of culture were added to each tube. The motility plates were prepared
with 0.3% and 0.4% LB agar in sterile petri dishes. Each of the five tubes was calculated
to an OD of 0.5 and 0.1. Once the agar plates were solidified and ready to use, four spots
of A. baumannii were injected into them, with two at an OD of 0.5 and two at an OD of
0.1 for each plate. A total of ten plates were inoculated, five in 0.3% agar and five in
0.4% agar, with and without each specific fatty acid. These plates were incubated
overnight at 37°C and analyzed for growth and motility the next day.
BACTERIAL RESISTANCE TO PEROXIDE STRESS, ANTIMICROBIAL PEPTIDE
RESISTANCE, AND ANTIBIOTIC RESISTANCE
The peroxide stress, antimicrobial peptide, and antibiotic resistance tests were prepared
and conducted identically, differing only in the concentrations and types of stresses used
against the bacteria. Overnight cultures were pelleted, washed with G-56, and used to
inoculate fresh culture in G-56 (with and without fatty acids) at a starting OD of 0.1. The
fatty acids used in this assay included 18:3γ , 20:3, 20:4, 20:5, and 22:6.
22:6 Triplicate and
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quadruplicate microtiter plates were prepared with a range of twofold dilutions of
hydrogen peroxide (10
10 mM - 640 mM), colistin (0.4 µg/mL
g/mL - 25.6 µg/mL
g/mL), imipenem (0.1
g/mL
µg/mL
g/mL - 0.64 µg/mL
g/mL),
), and polymyxin B ((1.6 µg/mL
g/mL - 102.4 µg/mL
g/mL). Each well was
inoculated with bacteria at a starting OD of 0.1, followed by incubation at 37°C
37° in a
shaking incubator for 20 hours. The plates were read the next day via the Biotek
Microplate reader with Gensys software at an absorbance of 600 nm.

V. RESULTS
GROWTH CURVE
The growth curve assay provided an overview pattern of growth for A. baumannii in the
presence
and
of

absence
various
fatty
acids.
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Flocculation, or cell aggregation
aggregation, began to appear as early as the 60-minute
minute mark for A.
baumannii enriched with 18:2 and 18:3α . All other cultures displayed flocculation within
120 minutes of growth. All of the media for this assay was prepared at 37°C in G-56
G
at
pH 7.4. As shown in the graph, growth patterns begin to diverge at around 480 minutes
between OD’s of 1.25 andd 1.5 (Fig 11). 18:3γγ reached the greatest optical density around
2.25, and the bacteria
teria withou
without fatty acids almost
lmost consistently had the slowest growth
levels, specifically when measured after the eight
eight-hour mark.. This indicates that
supplementation of A. baumannii with fatty acids may affect growth, particularly longlong
term growth.

THIN
LAYER

56 (pH 7.4) and
Figure 1: Growth patterns for A. baumannii with G-56
37°C grown in the absence of fatty acid as well as the presence of 18:2,
18:3αα , 18:3γ , 20:3, 20:4, 20:
20:5,
5, and 22:6. Optical density (600 nm) was
measured every 30 minutes for a total of eight hours, followed by
readings five hours later and 12 hours after that.. Bacteria grown in the
presence of fatty acids generally increased growth rates for A.
baumannii..
CHROMATOGRAPHY
Phospholipids were
and analyzed from A.

extracted
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baumannii in order to verify uptake of exogenous fatty acids in their own membranes, as
many other gram-negative bacteria have exhibited. The bacteria were grown in the
presence of various fatty acids, and their lipids were extracted and subjected to thin layer
chromatography. The chromatography showed different patterns and shifts of migration
with each of the different fatty acids. Specifically, A. baumannii with 18:3γ , 20:3
20: and
20:5 displayed higher migration compared to the other fatty acids (Fig 2).

ULTRA

Figure 2: Phospholipid profiles of A. baumannii grown in minimal
media (pH 7.4) and 37°C. The Bligh and Dyer method was used to
extract lipids, followed by thin layer chromatography.

PERFORMA
NCE LIQUID
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CHROMATOGRAPHY
The Bligh and Dyer extraction method for phospholipids was used to prepare A.
baumannii for phospholipid extraction. An extra wash step was included to increase
purity of the isolated lipids. Table 1 represents all significantly detected lipid species that
eluted from the column during chromatography and were detected by mass spectrometry.
The three chromatograms shown below (Fig 6) indicate quantitative and structural
differences among phospholipid species from each culture. The changes in retention time
as compared to the control indicate production of new phospholipid species when grown
with the indicated fatty acids. Many of the corresponding mass spectra are consistent with
the incorporation of the exogenous fatty acids into the phospholipids of A. baumannii
during growth at 37°C. Representative structures of predicted phosphatidylglycerol and
phosphatidylethanolamine species are shown for the selected exogenous fatty acids in the
first chromatogram. Corresponding phospholipid species were also identified for linoleic
acid (18:2), γ -linolenic acid (18:3γ ), dihomo-γ
dihomo -linolenic acid (20:3), arachidonic acid
(20:4), and docosapentaenoic acid (22:5), as shown in the second and third
chromatograms.

No FA

18:02

18:3 α

18:3 γ

18

20:3

20:4

20:5

22:5

22:6

654.6

686.4
688.4
690.3
700.2
702.2

686.2
688.5
690.4

684.5
686.2
688.5

684.5
686.4

684.2
688.5

690.4

688.5
690.6

680.6
682.3
684.2
686.4
688.5
690.4

682.6

682.4

688.4
690.6

686.4
688.5
690.6

702.1

702.6

706.1

714.4
716.4
719.6

710.3
712.5
714.5
716.5
717.4
719.4

710.2
712.5
714.3
716.5

710.4
712.4
714.4

719.2
721.3

719.6

734.4

742.2
744.3
745.5
747.4

738.3
740.3
741.5
742.2
743.4
745.5
747.4

738.4
740.1
742.4
743.3
745.4
747.4

708.4
710.4
712.5
716.4

712.3
714.3
716.5

708.5
710.4

714.4
716.4

714.5

714.5
716.5

719.3
721.4

719.2
721.7

719.4
721.3

736.5
738.6

734.4
736.5
738.4

734.4
736.5

734.5
736.6

742.5

742.6

742.6

745.5
747.4

744.5
745.4
747.6
752.5

719.4

728.4
734.5
738.4

710.4

740.5

743.3

747.4

743.6

747.4

745.3
747.4

745.2
747.6

756.4

764.5

762.4
764.4
765.4

762.3
764.5

760.5
762.5
764.5

767.4
769.7

767.4

767.4

766.4

773.3
775.4

769.4
771.6
773.5

769.2

769.2

769.6
771.5

773.3

773.3

773.3
775.5
782.4
788.5
790.6
793.4

782.5

793.5
795.3

Table 1: Spreadsheet representing all significantly detected lipid species (m/z of [MH]-) that were eluted from the C8 column during chromatography and detected by
mass spectrometry. Lipid species are categorized by the various fatty acids used
throughout UPLC.
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A

B

20

C

Figure 6: Ultra performance liquid chromatography (UPLC) and mass spectrometry
of A. baumannii phospholipid species. Bacteria were grown in G
G-56
56 (pH 7.4) at
37°C with or without various fatty acids. Phospholipids were dissolved in 50:50
mobile phase A:B and injected into a Waters UPLC with reversed-phase
reversed
C8 column.
Detection was quadropole mass spectrometry. The changes in retention time (and
mass spectra) are consistent with incorporation of the exogenous fatty acids into the
phospholipids of A. baumann
baumannii during growth in 37°C.. In Figure A, chromatograms
are shown for bacteria grown with 18:3
18:3α , 20:5, and 22:6; figure B represents
chromatograms for bacteria grown in the presence of fatty acids18:2, 18:3γ , and
20:3; figure C shows chromatograms for A. baumannii grown with 20:4 and 22:5.
Predicted structures are provided in A, reflecting the eluted phospholipid species.

CRYSTAL VIOLET UPTAKE
21

The purpose of thee crystal violet uptake assay was to identify changes in membrane
permeability in the presence of various fatty acids. While most of the experiments used
five core fatty acids, others were additionally incorporated for the crystal violet assay to
gain a better understanding of the role th
that fatty acids play. This hydrophobic compound
compoun
uptake test was conducted following bacterial growth in G-56 (pH 7.4)) at 37°C.
Membrane permeability of A. baumannii was affected as evidenced by differential uptake
of hydrophobic compounds (Fig 3). Growth in the presence of fatty acids resulted in
reduced uptake of CV. Five fatty acids (arachidonic, α -linolenic,
linolenic, docosahexaenoic,
docosapentaenoic, and eicosapentaenoic) exhibited 15
15-20% difference in permeability as
reflected by CV uptake.. The decrease in membr
membrane
ane permeability was evident for the
duration of the test.

Figure 3: Crystal violet hydrophobic compound uptake assay shown with A. baumannii
prepared in G-56
56 (pH 7.4) at 37°C.. The fatty acids used with the cultures were 18:2, 18:3α ,
18:3γγ , 20:3, 20:4, 20:5, 22:5, and 22:6. Crystal violet uptake was measured via optical
densities (590 nm) of the supernatant every five minutes for a total of 25 minutes. All
fatty acids inhibited crystal violet uptake to some degree.
BIOFILM FORMATION
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Biofilms are persistent, thick clusters of adhesive cells that increase their survival and
virulence on certain environmental surfaces, and assessing their formation is useful to
understanding their resistive nature and role in bacterial survival and persistence. 14
Bacteria that can form biofilms inherit a great deal of advantages, including their
resistivity, stability, and ability to cling to a variety of surfaces.15 The Centers for Disease
Control and Prevention and the National Institutes of Health claim that 65-80% of
microbe-related infections are related to the development of biofilms.16 The biofilm assay
was unique from the other experiments in that a number of different variables were tested
in the presence and absence of fatty acids, including temperature, pH, and type of
incubation. While the data looks similar and lacks significant growth of biofilms for A.
baumannii, as evidenced by OD, there are still some conclusions that can be drawn.
Based on experiments performed in octuplet, there were several observations of both
stimulatory and inhibitory effects of fatty acids on biofilm formation. At pH 5.5 and
37°C, 20:3 enhanced biofilm production, whereas 20:4 and 20:5 inhibited biofilm
production. At pH 7.4 and 37°C, 20:4 slightly increased the production of biofilms, while
18:3γ , 20:3, and 20:5 had very little effect.
effect Under conditions with pH 5.5 and 30°C, no
fatty acid enhanced biofilm production, but 18:3γ , 20:4, 20:5, and 22:6 decreased it by a
relatively significant amount. On the other hand, at pH 7.4 and 30°C, all fatty acids
boosted biofilm production to some degree except for 20:5, which inhibited it (Fig 4).
This is interesting to note because 30°C is our approximate skin temperature, and
biofilms have been known to cause numerous dermatologic diseases.17 When incubated
under shaking conditions, very little biofilm was detected (data not shown).
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pH 5.5, 37°C

pH 7.4, 37°C

Figure 4: Biofilm formation of A. baumannii grown in the absence and presence of fatty
acids (18:3γ , 20:3, 20:4, 20:5, and 22:6). Casamino acids were added to each set of
cultures, and the assays were performed at A) pH 5.5 and 37°C, B) pH 7.4 and 37°C, C)
pH 5.5 and 30°C, and D) pH 7.4 and 30°C. All graphs above show static growing
conditions. The asterisk marks (*) indicate data points reflecting statistical significant
differences from the no fatty acid control, as detected by p-value: A&C) p<0.002 and
B&D) p<0.02.

pH 7.4, 30°C

pH 5.5, 30°C

MOTILITY TEST
The literature cites motility as a difficult characteristic to examine with A. baumannii,
calling for a specific media called Eiken agar as an appropriate media for testing surface
motility.4 Because we did not have the means to access this agar from Japan, we
attempted our own assay based on previous research regarding A. baumannii motility.18,19
In lieu of Eiken agar, we conducted our motility test on 0.3% and 0.4% LB agar plates.
Unfortunately, no motility was exhibited on any of the plates after 24 hour incubation at
37°C. The strain of A. baumannii that is used in our lab (ATCC 17978) is non-motile due
to its absence of a flagellum, although it is known to exhibit a twitching motility.20
BACTERIAL RESISTANCE TO PEROXIDE STRESS, ANTIMICROBIAL PEPTIDE
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RESISTANCE, AND ANTIBIOTIC RESISTANCE
Because A. baumannii has become undoubtedly resistant to a number of stresses and
environments, we thought it was important to test whether their stress survival was
affected by potential modifications to ph
phospholipids
ospholipids or the cell membrane. The results for
these assays are shown in Figure 55. Prepared cultures were exposed to twofold
concentrations of hydrogen peroxide
peroxide,, imipenem, colistin, and polymyxin B for these
experiments. Hydrogen peroxide and iimipenem minimum inhibitory concentrations
concentration
(MICs) were not affected by the presence of fatty acids. In the peroxide stress and
antibiotic experiments, bacteria grown in the presence and absence of all fatty acids
followed a similar pattern, effectively being kille
killed
d off at around 320 mM hydrogen
peroxide and 0.16 µg/mL
g/mL imipenem. Exposure to polymyxin B resulted in increased
susceptibility for all fatty acids
acids, with the MIC decreasing from 25.6 to 12.8 for every fatty
acid except 18:3γγ , which decreased to 6.4 µg/mL
g/mL. Growth
wth in the presence of 18:3γ , 20:5,
and 22:6 led to increased susceptibility to colistin. As with PMB, 18:3γγ had the greatest
effect on survival.

A
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B

C

D
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Figure 5: MIC assays for A. baumannii following growth with fatty acids
and environmental stresses. Bacteria was grown in minimal media (G-56,
pH 7.4) at 37°C, followed by introduction of various concentrations of A)
hydrogen peroxide, B) imipenem, C) colistin, and D) polymyxin B. The
graphs above show the various degrees of resistance of A. baumannii to
these environmental stresses.

VI. DISCUSSION
The literature states that strains of A. baumannii mainly synthesize 18:1, 16:0, and
16:1 de novo.19 This means that all of the fatty acids used in our experiments had to be
incorporated into the bacteria through the mechanisms described previously. It was
certainly clear that the uptake of these fatty acids modified the cellular membrane, yet the
implications from experiment to experiment varied from one another. For example, in the
growth curve assay, it was observed that implementation of all fatty acids increased
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absorbance of the bacteria to some degree, with 18:3γ and 20:3 peaking highest of all at
the 780 minute mark. By adding fatty acids to A. baumannii, we were adding an external
carbon source that had the potential of increasing the growth rate of the bacteria, which is
what we found. While we do not know whether or not the fatty acids are being utilized as
extra carbon sources to make ATP by β -oxidation, we do know that the bacteria is
capable of incorporating the fatty acids into their membrane. It is likely that the carbon
source is used for longer survival rather than anything related to modifying the
membrane.
In the crystal violet assay, it was shown that incorporation of all fatty acids used
inhibit crystal violet uptake, which verified that the membrane had indeed been affected
by the introduction of various fatty acids. Nevertheless, A. baumannii with 18:3α , 20:4,
20:5, 22:5, and 22:6 exhibited a greater membrane alteration compared to the bacteria
with18:2, 18:3γ , and 20:3. It is interesting to note that the two groups of fatty acids
created that provided less or more crystal violet inhibition are also similarly classified as
ω -3 and ω -6 fatty acids, respectively. There is a clear distinction between ω -3 and ω -6 fatty
acids, and they both play an integral role in human health. From the PUFAs that were
used throughout my experiments, ω -3 fatty acids include 18:3α , 20:5, and 22:6, while the
ω -6 fatty acids are 18:2, 18:3γ , 20:3, and 20:4.21 These fatty acids are naturally occurring
in a lot of marine bacteria, which is of significance because some of these marine bacteria
have been found to be viably natural sources that hold antibiotic and antitumor
characteristics.22 Many of the ω -3 fatty acids in marine organisms have a different
pathway of interconverting PUFAs within their biological systems, and they are
beginning to become important in research related to human diet, health, and disease.23
Perhaps the differences observed in the crystal violet assay reflect differential
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incorporation between ω -3 and ω -6 fatty acids. If true, then our results indicate that ω -3
fatty acids may be preferentially assimilated into the membrane; or alternatively, ω -3 fatty
acids are intrinsically more refractory to passage of hydrophobic compounds.
One of the reasons why A. baumannii is such a highly resistant bacteria can be
attributed to its ability to form biofilms.24 The biofilms that we observed on our microtiter
plates grew on a hydrophobic material. Although the data initially did not seem to show
much, statistical analyses proved that there was an underlying implication to the
experiments. Two of the four graphs above exhibited a very significant p-value
(p<0.002), and interestingly enough, they were the two replicates performed under
conditions of pH 5.5. pH may play a bigger role than temperature for biofilm formation,
and this information could potentially be related to the pH values of the soil and
environments that A. baumannii thrive in. Biofilms are known to have the capability of
forming on plastic and glass materials, which are found in various pieces of medical
equipment throughout hospitals. This is noteworthy, as fatty acids are amphiphilic,
composed of hydrophobic and hydrophilic components, which should help biofilms form
more efficiently.
Although we tried manipulating various aspects while preparing A. baumannii for
these assays, the observed biofilm growth was modest without any overall consistency.
One reason why this occurred is because A. baumannii creates thicker biofilms at the
liquid-air border because of its aerobic nature, and the lack of oxygen at the bottom and
walls of microtiter wells are not conducive environments for them.23 The mechanism by
which many bacteria create biofilms is directly related to their locomotory moieties (pili,
flagella, glycopeptidolipids), but since none of these were detected in our motility
experiments, biofilm formation was most likely due to the ability of A. baumannii
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colonies to grow on these hydrophobic materials such as our polystyrene microtiter
plates.25
Strains of A. baumannii that are discovered in intensive care units and hospitals
carry antibiotic resistance that has proven to be troublesome over time. The antibiotics
and antimicrobial peptides used in this project had varying effects on the bacteria. Out of
the four environmental stresses that were tested in this portion of the project, colistin and
PMB showed the greatest variance of resistance when grown with different bacteria;
hydrogen peroxide and imipenem had little to no effect. The reason why a difference is
seen between the effects of imipenem versus colistin or polymyxin B is related to their
specific modes of inhibiting the bacteria. Imipenem is a β -lactam antibiotic that works by
binding to penicillin binding proteins (PBPs) and obstructing formation of the bacterial
cell wall.26 Since A. baumannii is a gram-negative bacterium, there is less peptidoglycan
for the antibiotic to get through to inhibit the cell altogether, and the pores formed
provide an easy route to inhibit the bacteria. On the other hand, colistin and polymyxin B
are cationic microbial peptides that have almost identical structures, differing in only one
amino acid. They work solely against gram-negative bacteria by interacting with
lipopolysaccharide (LPS).27 Lipopolysaccharide molecules are comprised of lipid A, a
core oligosaccharide, and a distal polysaccharide. Cationic microbial peptides disrupt the
calcium and magnesium bridges that hold LPS together and ultimately disturb the outer
membrane.28 This yields a cell membrane with amplified permeability and penetrability,
and the cell ultimately lyses.29,30 The addition of fatty acids contributes to this process by
altering the MICs of the antibiotics, as described in our results. Since the exposure to
PUFAs has no negative chemical or physiological effect on the human body, using them
to strengthen the sensitivity to drugs such as colistin and polymyxin B is quite possible in
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the future of medicine. It is also important to note the contributions of LPS to gramnegative bacterial resistance to cationic antimicrobial peptides. A key strategy is
modification of lipid A with positively charged moieties, which serve to repel cationic
antimicrobials.31
The effectiveness of β -lactam antibiotics like imipenem has a hypothesized
correlation to biofilm formation. It is believed that the strains of bacteria that can make
their own biofilms have less resistance to these antibiotics, as evidenced in our results.32
Strains that cannot form biofilms must rely on antimicrobial resistance because there are
no biofilms present to provide protection and virulence.
While A. baumannii is only one of 23 described species in the genus
Acinetobacter, its role as an opportunistic pathogen in human health and disease has
exponentially increased especially in the last two decades, now as a major threat in the
United States as well as many parts of Europe and Asia.33 One of the biggest problems we
face in healthcare is the increasingly arbitrary use of broad-spectrum antibiotics that have
caused an explosion of antibiotic-resistant bacteria, leaving doctors and scientists with
their last lines of defense against them.34 New drugs and medicines cannot keep up with
the rate of resistance in bacteria. That being said, many of the fatty acids used in our
experiments are known to have important functions in the body. For example, cell
growth, inflammation, and the central nervous system are controlled by the arachidonic
acid cascade, which is composed of over twenty signaling pathways. The pathway is
begun by arachidonic acid (20:4) and also requires 18:3α , 20:3, and 20:5 to properly
proceed.35 Knowing this information, it is perhaps feasible that we couuld incorporate
fatty acids into new strains of medication that can inhibit inflammatory responses from
the body in a more efficient manner. This is just one example of many to illustrate the
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important potential that this research could have in the field of microbial and clinical
medicine.
Data from UPLC and MS reported various phospholipid species present in A.
baumannii when grown with various fatty acids. The outer membrane of gram-negative
cells provides an extra, unique layer of protection to the cells. The asymmetrical outer
membrane is composed of a lipopolysaccharide outer leaflet and a phospholipid inner
leaflet. 95% of the inner membrane is made up of phosphatidylethanolamine and
phosphatidylglycerol head groups, which are the groups verified through UPLC-MS.36
Considering how many phospholipids make up the cell envelope of gram-negative
bacteria, the assimilation of exogenous fatty acids would be expected to significantly
alter membrane properties. Additionally, it is important to note that all of the fatty acids
used in this study contained cis bonds. It is unknown whether or not A. baumannii
possesses a cis-trans isomerase that can alter the fatty acid double bond conformation in
the membrane. These studies not only identify ramifications of exogenous fatty acids on
permeability and phospholipid composition, but also reveal phenotypic consequences that
may affect survival and pathogenesis of A. baumannii.
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VII. FURTHER STUDIES
Research shows that vaporized hydrogen peroxide (VHP) is used to treat
multidrug-resistant bacteria such as A. baumannii.3 Using VHP has proven to
dramatically decrease the number of bacterial cultures in the intensive care unit of
hospitals.37 Having learned this information, it would be of interest to revisit the hydrogen
peroxide assay and test the disinfecting abilities it may exhibit towards the bacteria in the
presence and absence of various fatty acids.
One assay whose modification we could potentially benefit from is the growth
curve assay. A long-term growth curve that goes to completion would show a better
overall image of the points at which the bacteria ultimately dies off. Although our growth
curve showed a progression of over 24 hours, a longer run could show us more. The fatty
acids used were not included in every assay that we conducted, but if they had been then
we would have seen significant increases in the effects measured and observed. It would

33

be worthwhile to replicate all of the assays in this project with direct incorporation of the
fatty acids to gain a better understanding of their function in bacterial cells.
Since biofilms are capable of forming on hydrophilic and hydrophobic surfaces,
and our studies were done on plastic microtiter plates, it would be interesting to see how
results would differ if the biofilm assay was performed on a glass surface. Also, using a
different mode of incubation aside from the microtiter plates would give insight to
whether or not our particular strain (ATCC 17978) forms greater biofilms at the liquid-air
border as opposed to the plastic walls of the microtiter wells.
Targeted MIC assays with various antibiotics to explore therapeutic potential of
fatty acids would be beneficial for further levels of studies. This could potentially help
determine if, how, and which fatty acids in conjunction with antibiotics or antimicrobial
peptides can diminish infectious pathogens like A. baumannii without affecting the
body’s natural microflora. Similar studies to this have been done with strains of
Streptococcus mutans using specifically targeted antimicrobial peptides (STAMPs).38 Due
to time and budget constraints, only selected fatty acids were used for the environmental
stress and even biofilm assays in comparison with the full spectrum used in the growth
curve. It would be beneficial to try all of the fatty acids and see if there is any consistency
of any particular ones throughout the various experiments in this project.
In addition, results warranting further study and analysis include the
chromatograms from the UPLC/MS. There is a significant amount of information
pertaining in the UPLC/MS data that has to be thoroughly analyzed in order to
understand the potential shifts in phospholipids among varying polyunsaturated fatty
acids. MS/MS analyses have already been planned for the lipid samples used in this
study. This approach determines whether the exogenous fatty acids are incorporated at
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the sn-1 or sn-2 position. Furthermore, the fatty acids used in this study contained cis
bonds. In order to determine the conformation of these fatty acids extracted from the
bacteria, fatty acid methyl esters could be generated and analyzed by gas chromatography
with appropriate standards.
While the extent of this project has been mainly with A. baumannii, many of the
mechanisms and functions among other gram-negative, antibiotic-resistant bacteria are
fairly similar. These bacteria include Escherichia coli, Pseudomonas aeruginosa, and
Klebsiella pneumoniae. It would be worthwhile to see the similarities and differences if
the experiments from this project were conducted on any of these other bacteria. By
doing so, we would be able to paint a broader picture of the role that fatty acids play in
the membrane and how this could affect the potential methods of treating and preventing
diseases caused by them on a global scale.
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